• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Generex Biotechnology Corp

+ Add to Watchlist

GNBT:US

0.0220 USD 0.0010 4.35%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Generex Biotechnology Corp (GNBT)

Open: 0.0216 Day's Range: 0.0206 - 0.0233 Volume: 1,727,682
Previous Close: 0.0230 52wk Range: 0.0200 - 0.0560 1-Yr Rtn: -42.58%

Stock Chart for GNBT

No chart data available.
  • GNBT:US 0.0220
  • 1D
  • 1M
  • 1Y
0.0230
Interactive GNBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNBT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0150
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 17.08
Shares Outstanding (M) 776.56
30 Day Average Volume 2,590,803
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNBT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNBT

Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.

Mark A FletcherPresident/Exec VP/CEOStephen FellowsChief Financial Officer
David A BrusegardCOO/SecretaryEric Von HofeVice President
More Company Profile & Key Executives for GNBT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil